Wendy Rubinstein looks at why getting genomics to physicians’ desks is proving so problematic
When it comes to prenatal genomics, there aren’t many bigger names than Diana Bianchi
Eric Green has been involved in genomics from the very beginning, from the first human genome to the NHGRI. Was he always destined for a career in genomics?
Over the past few years, the role of genomics in the clinic has expanded enormously. At the forefront is the Genomes2People (G2P) Research Program
Ahead of this year’s Festival in Boston, and another all-star production of DNA Dialogues, Dilemmas and Drama, we sat down with Lynn Bush to find out more about her inspiration.
We discuss cancer diagnostics and digital PCR with George Karlin-Neumann, scientific director of affairs at Bio-Rad’s Digital Biology Center
We spoke to Katia Moritz, clinician, filmmaker, and patient advocate about her film Undiagnosed: Medical Refugees
Front Line Genomics met with Nazneen Aziz to understand where the war on cancer will be won.
How long-read sequencing technologies are becoming smaller, cheaper and more accessible.
Genetic counsellor, Anna Middleton explains how the advent of genomics is changing the way that counsellors work.
Carl Zimmer, columnist at The New York Times, shares advice about science writing and communication.
Aubrey de Grey of SENS Research Foundation is working to cure ageing.
In conversation with BERG’s Niven Narain about changing drug development through artificial intelligence.
How can we involve patients in the research that will affect their lives?
From Issue 5 of FLG Magazine, Illumina CEO Jay Flatley answers our questions on long reads, single molecules, and $1000 genomes.